Combating Muscle Loss in Diabetes: Effective Strategies for Elderly Patients

Learn how to prevent and manage sarcopenia (muscle loss) in older adults with diabetes. Discover key steps like blood sugar control, proper nutrition, exercise, and medication choices to improve their muscle function, quality of life, and overall health.

DR T S DIDWAL MD

3/4/20245 min read

Combating Muscle Loss in Diabetes: Effective Strategies for Elderly Patients
Combating Muscle Loss in Diabetes: Effective Strategies for Elderly Patients

According to a new review published in the journal Frontiers in Endocrinology, sarcopenia (muscle loss) and diabetes are common and concerning issues in older adults. They worsen each other, with diabetes raising the risk of sarcopenia and vice versa. This can significantly impact their daily lives, health, and lifespan. Early detection and treatment are crucial. Effective strategies include exercise, a balanced diet with enough protein, medications for blood sugar control, and healthy lifestyle changes.

Key Points

Sarcopenia:

  • Loss of muscle mass, strength, and function.

  • It affects daily activities, increases fall risk, and shortens life expectancy.

  • More prevalent in older individuals (10–30%).

  • Caused by factors like age, an unbalanced diet, physical inactivity, inflammation, and chronic diseases.

Diabetes:

  • Chronic metabolic disease with high blood sugar levels.

  • Over 60% of elderly individuals have diabetes or prediabetes.

  • Can lead to complications like cardiovascular issues, kidney problems, and vision impairment.

The two conditions are linked and worsen each other:

  • Diabetes increases the risk of sarcopenia due to factors like insulin resistance, inflammation, and reduced physical activity.

  • Sarcopenia can worsen diabetes by impacting blood sugar control.

Early identification and treatment are crucial.

Treatment strategies for sarcopenia in the elderly:

  • Physical exercise: improves muscle quality and strength.

  • Balanced diet: Adequate protein and nutrients are essential.

  • Pharmacological therapies: may help control blood sugar and prevent muscle loss.

  • Lifestyle changes: Promote overall health and well-being.

Sarcopenia, a condition characterized by the progressive loss of muscle mass, strength, and function, poses a significant health concern, particularly among the elderly population. This article aims to provide an in-depth understanding of sarcopenia, covering its definition, prevalence, diagnosis process, and associated risk factors.

Definition and Prevalence of Sarcopenia

Sarcopenia, a term first coined by Rosenberg in 1989, refers to the age-related decline in muscle mass and/or strength. The European Working Group on Sarcopenia in the Elderly (EWGSOP) defined sarcopenia in 2010 as a generalized decrease in muscle mass and/or strength. Subsequently, in 2018, the definition was revised to include the loss of muscle function.

The prevalence of sarcopenia varies across studies due to different cutoffs and measurement methods. However, meta-analyses suggest that the prevalence among adults over 60 ranges from 10 to 27 per cent. With the aging global population, the number of sarcopenia cases is expected to rise steadily.

Diagnosis and Treatment of Sarcopenia

The diagnostic process for sarcopenia involves a comprehensive assessment of muscle mass, strength, and function. The EWGSOP introduced the Find-Assess-Confirm-Severity approach for diagnosis, emphasizing the severity of sarcopenia when low muscle strength, mass, and physical function are all detected.

SARC-F Questionnaire

The SARC-F questionnaire, a five-item self-assessment tool, is recommended by the EWGSOP for assessing sarcopenia risk. Despite its widespread use, the SARC-F questionnaire has limitations in sensitivity and specificity. To improve accuracy, the SARC-CalF approach combines SARC-F with maximum leg circumference.

Muscle Strength

Muscle strength, measured by grip strength and functional tests like the chair stand test, serves as a key indicator of sarcopenia. Grip strength correlates with overall muscle strength and is easily assessable, making it a valuable measurement tool.

Muscle Mass

Various methods, including CT, MRI, DXA, and BIA, are employed to estimate muscle mass. While CT and MRI offer high accuracy, DXA and BIA provide more accessible alternatives, particularly in community settings.

Muscle Function

Assessment of muscle function involves tests like daily gait speed and the short physical performance battery (SPPB). These tests evaluate mobility and functional abilities, crucial for diagnosing sarcopenia.

Risk Factors of Sarcopenia

Sarcopenia is influenced by both intrinsic and extrinsic factors. Intrinsic factors include age, hormonal changes, mitochondrial dysfunction, and chronic inflammation. Aging directly impacts muscle quality and function, leading to the gradual loss of muscle mass and strength.

Intrinsic Factors

Age is a significant intrinsic risk factor for sarcopenia. As individuals age, changes in muscle quality, hormone levels, and mitochondrial function contribute to muscle loss. Moreover, chronic inflammation associated with aging exacerbates sarcopenia.

Extrinsic Factors

Lack of exercise, a sedentary lifestyle, and obesity are major extrinsic factors contributing to sarcopenia. Physical inactivity leads to muscle atrophy, while obesity exacerbates muscle dysfunction. Other factors, such as chronic stress and exposure to pollutants, also increase the risk of sarcopenia.

Pathogenesis of Interaction Between Sarcopenia and T2DM

The interaction between sarcopenia and type 2 diabetes mellitus (T2DM) is complex and multifaceted.

Insulin Resistance and Muscle Mass

Insulin resistance, a hallmark of T2DM, contributes to muscle atrophy by impairing glucose uptake and protein synthesis in muscle tissue. This leads to a vicious cycle of muscle loss and worsened glycemic control.

Hyperglycemia

Hyperglycemia in T2DM exacerbates sarcopenia through the formation of advanced glycation end products, oxidative stress, and inflammation. It impairs muscle function and metabolism, accelerating muscle loss.

Oxidative Stress and Inflammatory reactions

Chronic inflammation and oxidative stress play crucial roles in muscle atrophy in individuals with T2DM. These factors disrupt muscle metabolism and promote muscle degradation, worsening sarcopenia.

Sarcopenic Obesity

Sarcopenic obesity, characterized by the coexistence of sarcopenia and obesity, is prevalent among elderly individuals with T2DM. It exacerbates muscle dysfunction and metabolic abnormalities, creating a cycle of worsening health outcomes.

Comprehensive Treatment Strategies

Intervention Measures to Reduce Sarcopenia and Adverse Outcomes in Elderly with Diabetes

Sarcopenia (muscle loss) and diabetes are common, concerning issues in older adults, worsening each other and impacting their health and lifespan. Early detection and intervention are crucial. Here are key measures:

1. Blood Sugar Control:

  • Effective management of blood sugar slows muscle loss and reduces protein breakdown.

  • Stable insulin levels contribute to muscle protein synthesis, promoting muscle quality and strength.

  • Well-controlled blood sugar can prevent sarcopenia onset and enhance overall muscle function.

2. Nutritional Intervention:

  • Protein: Higher protein intake (1.2-1.5g/kg/day) is crucial for muscle synthesis, blood sugar control, and weight management.

  • Essential Amino Acids: Adequate intake, especially leucine, stimulates muscle protein synthesis and improves muscle mass, strength, and walking ability.

  • Vitamin D and Calcium: Deficiency is linked to increased sarcopenia risk. Supplementation can improve muscle function and reduce falls, especially in the elderly with chronic diseases.

  • Omega-3 Fatty Acids: Intake has been linked to reduced sarcopenia incidence and improved muscle quality and strength. They may also reduce inflammation.

3. Physical Exercise:

  • Regular physical activity, particularly resistance training, is vital for preventing and treating sarcopenia in the elderly with diabetes.

  • It improves muscle quality and function, reduces insulin resistance, and combats the decline in activity ability due to age-related diseases.

  • International guidelines recommend resistance training at least twice a week for patients with type 2 diabetes.

4. Selection of Antidiabetic Drugs:

  • Some drugs, like sulfonylureas, may be linked to muscle loss.

  • Insulin sensitizers like metformin may slow down muscle loss, while insulin administration may improve muscle mass or gait speed, but with potential weight gain.

  • Further research is needed to fully understand the complex relationship between specific drugs and sarcopenia.

Effective prevention and treatment require a multi-pronged approach:

  • Dietary intervention: Rich in protein, essential amino acids, vitamin D, calcium, and omega-3 fatty acids.

  • Regular physical exercise: Tailored to individual needs and abilities, with emphasis on resistance training.

  • Management of blood sugar level and improvement of insulin resistance.

  • Careful consideration of antidiabetic drugs, keeping sarcopenia in mind.

Early detection, screening, and diagnosis of sarcopenia in diabetic individuals are crucial. By implementing these comprehensive strategies, healthcare professionals can significantly improve the muscle function, quality of life, and overall well-being of the elderly population facing both sarcopenia and diabetes.

Conclusion

In conclusion, optimizing treatment strategies for sarcopenia in diabetic patients requires a multifaceted approach. Blood sugar control, nutrition intervention, physical exercise, and judicious selection of antidiabetic drugs are key components of comprehensive management. Healthcare professionals must prioritize early prevention and intervention to mitigate muscle loss in elderly diabetic patients.

Journal Reference

Hou, Y., Xiang, J., Wang, B., Duan, S., Song, R., Zhou, W., Tan, S., & He, B. (2024, January 8). Pathogenesis and comprehensive treatment strategies of sarcopenia in elderly patients with type 2 diabetes mellitus. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2023.1263650

Related

https://healthnewstrend.com/study-links-daily-activity-patterns-to-body-fat-and-cardiometabolic-biomarkers

https://healthnewstrend.com/low-uric-acid-levels-linked-to-increased-sarcopenia-risk-a-new-tool-for-early-detection

Medical Disclaimer

The information on this website is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.